Formulations for wound therapy
US9717821B2 · kind B2 · utility
17Cited by
6References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 6, 2012 |
| Grant date | Aug 1, 2017 |
| Priority date | — |
| Expiry date | Jan 14, 2033 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61L2430/34
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to novel formulations comprising a dry powder fibrin sealant comprised of a mixture of fibrinogen and/or thrombin, for use in the treatment of wounds or injuries, in particular for use as a topical hemostatic composition or for surgical intervention.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.